NEW : European Medicines Agency discourages new Raptiva prescriptions . Raptiva 's product labeling was revised in October to highlight risks . Raptiva is an injection for adults with moderate to severe plaque psoriasis . The FDA has approved the drug, but it remains unclear whether patients will be able to get their medication from pharmacies or doctors.
NEW : European Medicines Agency discourages new Raptiva prescriptions . Raptiva 's product labeling was revised in October to highlight risks . Raptiva is an injection for adults with moderate to severe plaque psoriasis . The drug suppresses T-cells , which makes it decrease immune system function .